Breuer; Aviva

Patent Applications and Registrations

Patent applications and USPTO patent grants for Breuer; Aviva.The latest application filed is for "method for treating pain or associated condition or symptom".

Company Profile

2.13.13

Breuer; Aviva - Jerusalem IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for treating pain or associated condition or symptom Grant 11,149,014 - Gallily , et al. October 19, 2	2021-10-19
Fluorinated CBD compounds, compositions and uses thereof Grant 10,441,553 - Mechoulam , et al. Oc	2019-10-15
Method For Treating Pain Or Associated Condition Or Symptom App 20190169148 - Gallily; Ruth ; et al.	2019-06-06
Cyclohexenyl compounds, compositions comprising them and uses thereof Grant 10,239,848 - Gallily , et al.	2019-03-26
Fluorinated Cbd Compounds, Compositions And Uses Thereof App 20190084909 - Mechoulam; Raphael ; et al.	2019-03-21
Fluorinated Cbd Compounds, Compositions And Uses Thereof App 20170326078 - MECHOULAM; Raphael ; et al.	2017-11-16
Fluorinated CBD compounds, compositions and uses thereof Grant 9,782,360 - Mechoulam , et al. October 10, 2	2017-10-10
Fluorinated Cbd Compounds, Compositions And Uses Thereof App 20170197904 - MECHOULAM; Raphael ; et al.	2017-07-13
Cyclohexenyl Compounds, Compositions Comprising Them And Methods App 20170029391 - GALLILY; Ruth ; et al.	2017-02-02
Fluorinated CBD compounds, compositions and uses thereof Grant 9,447,019 - Mechoulam , et al. September 20, 2	2016-09-20
Fluorinated Cbd Compounds, Compositions And Uses Thereof App 20150344403 - MECHOULAM; Raphael ; et al.	2015-12-03
Anti-nausea and anti-vomiting activity of cannabidiol compounds Grant 8,119,697 - Mechoulam , et al. February 21, 2	2012-02-21
Compositions Comprising Cb Receptor Agonists, Uses Thereof And Methods For Their Preparation App 20110269842 - Bab; Itai ; et al.	2011-11-03
Pharmaceutical compositions comprising cannabidiol derivatives Grant 7,759,526 - Mechoulam , et al. July 20, 2	2010-07-20
Agonists specific for the peripheral cannabinoid receptor Grant 7,214,716 - Fride , et al. May 8, 2	2007-05-08
Anti-nausea and anti-vomiting activity of cannabidiol compounds App 20070049645 - Mechoulam; Raphael ; et al.	2007-03-01
Agonists specific for the periperal cannabinoid receptor App 20050165118 - Fride, Ester ; et al.	2005-07-28
Agonists specific for the peripheral cannabinoid receptor Grant 6,903,137 - Fride , et al. June 7, 2	2005-06-07
Agonists specific for the peripheral cannabinoid receptor Grant 6,864,291 - Fride , et al. March 8, 2	2005-03-08
Anti-nausea and anti-vomiting activity of cannabidiol compounds App 20030225156 - Mechoulam, Raphael ; et al.	2003-12-04
Pharmaceutical compositions comprising cannabidiol derivatives App 20030166727 - Mechoulam, Raphael ; et al.	2003-09-04
Agonists specific for the peripheral cannabinoid receptor App 20020173528 - Fride, Ester ; et al.	2002-11-21
2-Arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor-alpha and neuroprotector of brain in closed head injury App 20020072539 - Mechoulam, Raphael ; et al.	2002-06-13
(3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing them Grant 5,635,530 - Mechoulam , et al.	1997-06-03
Certain tetrahydrocannabinol-7-oic acid derivatives Grant 5,538,993 - Mechoulam , et al.	1996-07-23
Neuroprotective pharmaceutical compositions of 4-phenylpinene derivatives and certain novel 4-phenylpinene compounds Grant 5,434,295 - Mechoulam , et al.	1995-07-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.